ORAL IDARUBICIN IN THE TREATMENT OF ADVANCED BREAST-CANCER

被引：4

作者：

BASTHOLT, L

DALMARK, M

JAKOBSEN, A

GADEBERG, CC

SANDBERG, E

MOURIDSEN, HT

机构：

[1] ESBJERG CENT HOSP,ESBJERG,DENMARK

[2] RIGSHOSP,FINSEN INST,DEPT ONCOL,DK-2100 COPENHAGEN O,DENMARK

[3] AARHUS UNIV HOSP,DK-8000 AARHUS C,DENMARK

[4] VEJLE HOSP,VEJLE,DENMARK

来源：

ACTA ONCOLOGICA | 1989年 / 28卷 / 06期

关键词：

D O I：

10.3109/02841868909092327

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：893 / 897

页数：5

共 24 条

[1]

BASTHOLT L, 1987, CANCER TREAT REP, V71, P451

[2]

CARMOPEREIRA J, 1986, P ASCO, V5, P218

[3]

CHLEBOWSKI RT, 1980, CANCER TREAT REP, V64, P47

[4]

CREECH RH, 1980, P AM ASSOC CANC RES, V21, P142

[5] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY [J].

FREI, E ;

CANELLOS, GP .

AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :585-594

[6] WEEKLY ADRIAMYCIN VERSUS VAC IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL [J].

GUNDERSEN, S ;

KVINNSLAND, S ;

KLEPP, O ;

KVALOY, S ;

LUND, E ;

HOST, H .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (12) :1431-1434

[7]

HASKELL CM, 1974, CANCER RES, V34, P2991

[8]

HOOGSTRATEN B, 1979, Cancer Clinical Trials, V2, P101

[9] THE IMPORTANCE OF DOSE INTENSITY IN CHEMOTHERAPY OF METASTATIC BREAST-CANCER [J].

HRYNIUK, W ;

BUSH, H .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (11) :1281-1288

[10]

KRARUPHANSEN A, 1987, 4 P ECCO

← 1 2 3 →